Activity and tolerability of buprenorphine after parenteral and sublingual administration.
D000284:Administration, Oral; D001784:Blood Gas Analysis; D002047:Buprenorphine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009019:Morphinans / Q000627:therapeutic use*; D009060:Mouth Floor; D010146:Pain / Q000188:drug therapy*; D013997:Time Factors
D009019:Morphinans; D002047:Buprenorphine